Inflammation as a therapeutic target in heart failure with preserved ejection fraction

Inflammation as a therapeutic target in heart failure with preserved ejection fraction

Heart failure with preserved ejection fraction (HFpEF) accounts for around half of all cases of heart failure and may become the dominant type of heart failure in the near future. Unlike HF with reduced ejection fraction there are few evidence-based treatment strategies available. There is a signifi...

Full description

Bibliographic Details
Main Authors: Zhen Hui Peh, Adel Dihoum, Dana Hutton, J. Simon C. Arthur, Graham Rena, Faisel Khan, Chim C. Lang, Ify R. Mordi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
inflammation
heart failure
HFpEF
interleukins
cardiometabolic
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1125687/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1125687/full

Similar Items